Shorepoint Capital Partners LLC Abb Vie Inc. Transaction History

Shorepoint Capital Partners LLC

$426 Million
Q3 2024

A detailed history of Shorepoint Capital Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Shorepoint Capital Partners LLC holds 35,136 shares of ABBV stock, worth $6.22 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

35,136

Previous 37,077 5.24%

Holding current value

$6.22 Million

Previous $6.36 Million 9.11%

% of portfolio

1.63%

Previous 1.53%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $318,013 - $386,899	-1,941 Reduced 5.24%	35,136 $6.94 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $8,203 - $9,580	-53 Reduced 0.14%	37,077 $6.36 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $370,622 - $422,289	-2,319 Reduced 5.88%	37,130 $6.76 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $960,723 - $1.08 Million	-6,982 Reduced 15.04%	39,449 $6.11 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $446,324 - $516,685	-3,341 Reduced 6.71%	46,431 $6.92 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $464,845 - $578,469	-3,508 Reduced 6.58%	49,772 $6.71 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.06 Million - $1.22 Million	-7,310 Reduced 12.06%	53,280 $8.49 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.61 Million - $1.93 Million	11,608 Added 23.7%	60,590 $9.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $97,302 - $111,599	725 Added 1.5%	48,982 $6.57 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $491,165 - $624,432	-3,569 Reduced 6.89%	48,257 $7.39 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $523,828 - $649,923	-3,969 Reduced 7.11%	51,826 $8.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $52,103 - $65,926	485 Added 0.88%	55,795 $7.56 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $698,728 - $793,162	6,567 Added 13.47%	55,310 $5.97 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $2.83 Million - $3.11 Million	-27,620 Reduced 36.17%	48,743 $5.28 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $11,107 - $14,996	138 Added 0.18%	76,363 $8.18 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $245,530 - $288,172	-2,858 Reduced 3.61%	76,225 $6.68 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $811,765 - $1.09 Million	-11,064 Reduced 12.27%	79,083 $7.76 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $315,856 - $478,877	-4,897 Reduced 5.15%	90,147 $6.87 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $83,310 - $104,238	-1,155 Reduced 1.2%	95,044 $8.42 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $187,869 - $225,872	2,983 Added 3.2%	96,199 $7.28 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $402,281 - $514,209	6,123 Added 7.03%	93,216 $6.78 Million
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $6.72 Million - $7.91 Million	87,093 New	87,093 $7.02 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.

Account

Shorepoint Capital Partners LLC Abb Vie Inc. Transaction History